🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a proof-of-concept study to demonstrate if a daily dose of a ...
Status
Completed
Location
Investigational Site Number : 1240001
Start Date
2023-01-23
Trial ID
NCT05692154
Treatments Being Tested
Sphenopalatine ganglion (SPG)-acupuncture has been shown to exhibit distinc...
Status
Completed
Location
Beijing Tongren Hospital
Start Date
2016-01-16
Trial ID
NCT03282630
Treatments Being Tested
Single dose (four sprays) bioequivalence study of Azelastine Hydrochloride/...
Status
Completed
Location
Cliantha Research Limited
Start Date
2023-03-24
Trial ID
NCT06180083
Treatments Being Tested
The primary objective of this placebo-controlled EEU study is to determine ...
Status
Completed
Location
Altana/Nycomed
Start Date
2005-02
Trial ID
NCT00659503
Treatments Being Tested
The objective of this study is to evaluate ocular and nasal signs and sympt...
Status
Completed
Location
Ophthalmic Research Associates, Inc
Start Date
2008-12
Trial ID
NCT00985075
Chitin microparticles (CMP) has been demonstrated in animal studies that ha...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00443495
Treatments Being Tested
This study is a multicenter, single arm, open-label phase II clinical study...
Status
Completed
Location
Beijing Tong-Ren hospital
Start Date
2023-08-23
Trial ID
NCT05908721
Treatments Being Tested
To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for...
Status
Completed
Location
Multiple Locations
Start Date
2003-08
Trial ID
NCT00525278
Treatments Being Tested
This study is designed to assess the effectiveness of mometasone furoate na...
Status
Completed
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT00453063
Treatments Being Tested
This study will investigate whether a single dose QAX576 (an interleukin-13...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-12
Trial ID
NCT00584584